What BIOMODEX does

BIOMODEX is a Paris-headquartered medical technology company founded in 2015 by Thomas Marchand and Sidarth Radjou that develops patient-specific 3D-printed anatomical twins, marketed as biorealistic haptic simulators, for physician training and pre-operative rehearsal. The proprietary technology stack centers on INVIVOTECH (multi-material 3D printing that reproduces tissue-like biomechanical behavior from CT, MRI, or 3D rotational angiography inputs), ECHOTECH (ultrasound-compatible imaging properties for TEE and ICE), BLOODSIM (blood-analog fluid with matched viscosity and density), and THROMBOTECH (hydrogel synthetic clots), combined with Stratasys J750 Digital Anatomy 3D printers in Paris and Quincy, MA.

The product portfolio spans neurovascular (EVIAS Plus for unruptured aneurysm rehearsal and ischemic stroke mechanical thrombectomy, plus Aortic Arch Catheterism), cardiovascular (LAACS for left atrial appendage closure, Transseptal Puncture Training, Aortic System for TAVI/TAVR and valve-in-valve), and endovascular (EVAR for abdominal aortic aneurysm) applications, delivered as lightweight plug-and-play stations with a 5-day image-to-model turnaround. The company sells direct to hospitals and academic medical centers (Toronto Western, CHU Rennes, Fondation Adolphe de Rothschild, Beth Israel Lahey Health, Montreal Heart Institute) and to medical device manufacturers (Boston Scientific, Stryker, Corindus/Siemens Healthineers) for product validation, clinical studies, and physician training programs.

BIOMODEX generates revenue through hardware sales of simulation stations and disposable/reusable anatomical cartridges, supplemented by services tied to clinical studies and device launch support, with custom quotation-based enterprise pricing and multi-year contracts. Following Series A funding of $15M in June 2018 (total financing above $18.5M), the company established US operations, secured ISO 13485:2016 certification in 2020, and was ultimately acquired by Mentice AB in 2025, which acquired substantially all assets and integrated Biomodex into its endovascular simulation portfolio.

Name

BIOMODEX

Legal name

Biomodex

Website

https://biomodex.com

Company type

Private

Founded year

2015

Operating status

Acquired

Headcount range

51–100 employees

Short description

BIOMODEX is a Paris-based medical technology company that develops 3D-printed patient-specific anatomical twins with haptic feedback for physician training and pre-operative rehearsal, serving hospitals, academic medical centers, and medical device manufacturers across neurovascular, cardiovascular, and endovascular procedures.

Ownership category

akta.pro rank

Product category

Medical Simulation Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction) (EDAFAJAC)

akta.pro secondary industries

Medical & Dental 3D Printing Services (patient-specific devices, dental labs) (IMAAADAG), Medical & Dental Prototyping (Models, Guides, Pre-Op Planning) (IMAAAFAI), Digital Twins & Scenario-Based Systems Training (Equipment/Process Simulators) (EDAFAJAJ)

Keywords

• Medical simulation devices
• 3D printed anatomical models
• Surgical rehearsal systems
• Haptic physician training
• Interventional procedure simulation

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. 3D Printed Anatomical Models: Sale of patient-specific 3D printed anatomical twin cartridges and simulation stations. Each printer can produce dozens of anatomical model cartridges per day.
2. Medical Device Validation Services: Services to major medtech manufacturers including Boston Scientific and Stryker to validate new product lines and conduct clinical studies.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

BIOMODEX manufactures and sells patient-specific 3D-printed anatomical twin simulators paired with portable plug-and-play stations for pre-procedural rehearsal and physician training across neurovascular, cardiovascular, and endovascular specialties. The offering combines proprietary INVIVOTECH biomechanical printing, ECHOTECH ultrasound-compatible imaging, and BLOODSIM blood-analog fluid dynamics to produce biorealistic haptic simulators used by hospitals, medical device manufacturers, and fellowship programs.

Product overview

BIOMODEX is a digital health company offering biorealistic haptic simulators for patient-specific rehearsal and physician training. The portfolio centers on two main simulation platforms: EVIAS Plus for neurovascular applications (including unruptured aneurysm and ischemic stroke training) and LAACS for cardiovascular applications (including left atrial appendage closure and transseptal puncture training). These are complemented by the Aortic System for valve procedures, EVAR System for abdominal aortic aneurysm, and Aortic Arch Catheterism modules. The systems combine 3D-printed patient-specific anatomical models with proprietary INVIVOTECH (biomechanical properties), ECHOTECH (ultrasound imaging compatibility), BLOODSIM (fluid dynamics), and Thrombotech (clot simulation) technologies, delivered through lightweight portable plug-and-play stations. The company operates from Paris and Boston, serving hospitals, medical device companies, and physicians across the U.S. and Europe.

Differentiator

Problem solved

Functional benefit

Brands

• EVIAS™: EndoVascular Intracranial Aneurysm System - patient-specific 3D printed models for neurovascular procedures
• LAACS™
• EVIAS Plus™
• Transseptal Puncture Training

Products and services

• EVIAS Plus (EndoVascular Ischemic & Aneurysm System) A neurovascular simulation system providing patient-specific 3D-printed anatomical models with haptic feedback for practicing intracranial aneurysm procedures and ischemic stroke treatment, including flow diversion, coil embolization, stent placement, and mechanical thrombectomy. Targeted at neurointerventionalists at hospitals and medical device manufacturers.
• LAACS (Left Atrial Appendage Closure System) A cardiovascular training and rehearsal solution for left atrial appendage closure procedures, featuring TEE-compatible 3D-printed models with proprietary ECHOTECH and INVIVOTECH technologies for realistic imaging and haptic feedback. Used by interventional cardiologists and structural heart specialists at hospitals and medical device manufacturers.
• Aortic System A cardiovascular simulation solution for aortic valve procedures including TAVI, TAVR, and valve-in-valve interventions, providing anatomical twins with femoral, transapical, and subclavian access points. Used to train interventional cardiologists and structural heart teams.
• Transseptal Puncture Training Solution An echo-guided training system for transseptal puncture procedures using LAACS station compatibility, featuring ultrasound (TEE/ICE) compatible 3D-printed models with realistic haptic feedback and reusable frame with single-use septums. Targeted at electrophysiologists, interventional cardiologists, and fellowship programs.
• Aortic Arch Catheterism A neurovascular training solution for aortic arch catheterization procedures, featuring multi-use Type I/II/III aortic arch cartridges compatible with the EVIAS Plus station, with right femoral and radial access options. Used by neurointerventionalists and trainees learning catheter access.
• EVAR System (EndoVascular Repair System) An endovascular training and rehearsal solution for unruptured abdominal aortic aneurysm procedures, providing anatomical twins with femoral access, physiological flow circulation, and contrast agent compatibility for EVAR, laser fenestration, and chimney procedures. Used by vascular surgeons and interventional radiologists.

Quantifiable outcome

• Reliable reproduction of aneurysm features and parent vessel anatomy between 3D models and patient anatomy (per JNIS clinical study)
• +3 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Seven partnerships are on record, tiered strategic, supporting and core.

• Montreal Heart InstitutestrategicStrategic or Co-development Partner · 5 January 2022Partnering to develop new cardiovascular training solution for pulsatile heart models to help cardiologists rehearse and train for complex valve-in-valve procedures.
• Axial3DsupportingTechnology or Integration · 8 December 2021Partnership with Belfast medical imaging firm to speed up production of 3D-printed brain aneurysm models by cutting time to transform 2D medical images to 3D visuals.
• Avail MedsystemsstrategicGTM or Marketing Partner · 17 September 2021Collaboration to expand access to virtual medical education through live broadcasting of physician training and rehearsals. Enables live-streaming of Biomodex simulations for remote learner engagement.
• StratasyscoreTechnology or IntegrationStrategic partnership using Stratasys J750 Digital Anatomy 3D Printers. Biomodex has two printers in Paris and one in Quincy facility. Long-standing relationship with plans to continue collaborating on new software and systems.
• Dassault SystèmessupportingTechnology or IntegrationStrategic supporter providing cloud access to design and simulation software and helping transition to cloud environment.
• Corindus (Siemens Healthineers)strategicStrategic or Co-development PartnerCollaboration for world's first in-human robotic-assisted neurovascular intervention. Biomodex EVIAS models used to rehearse robotic stent-assisted coiling procedures.
• Medical Device ManufacturerscoreChannel Partner/ Reseller/ DistributorPartnerships with medical device manufacturers for validation of new product lines, conducting clinical studies, and physician training programs.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Mentice AB: Public Swedish endovascular simulation company that acquired BIOMODEX's assets in 2025. Offers virtual reality-based interventional training and now combines its software simulators with BIOMODEX's physical anatomical twins, making it the most directly comparable and overlapping player in the endovascular simulation space.
• CAE Healthcare: Division of CAE Inc. providing full-body manikin-based simulation and ultrasound/patient simulation training for medical education. Broad incumbent in healthcare simulation with established hospital sales channels and complementary procedural training products that partially overlap with BIOMODEX's training use case.
• 3D Systems (Simbionix): Acquired Simbionix to offer patient-specific surgical simulation and virtual reality training, alongside its core 3D printing business. Overlaps with BIOMODEX in both procedural simulation and 3D-printed anatomical models for surgical planning and training.

Direct peers

• Surgical Theater: Provides VR-based patient-specific surgical rehearsal and 360-degree visualization platforms for neurosurgery and other complex procedures. Competes with BIOMODEX in the patient-specific pre-operative rehearsal use case, but via virtual reality rather than 3D-printed physical models.
• FundamentalVR: Offers haptic-enabled VR surgical training with multi-subject procedures including ophthalmology and orthopedics. Competes directly with BIOMODEX's EVIAS Plus and LAACS platforms by delivering realistic tactile feedback through software, providing a lower-cost, more scalable alternative to physical anatomical twins.
• Materialise: Belgian 3D printing services and software company with a dedicated medical division providing patient-specific surgical planning models, anatomical prints, and implants. Competes with BIOMODEX in patient-specific 3D-printed anatomical models for pre-operative planning across cardiovascular and orthopedic specialties.
• Axial3D: Belfast-based medical 3D printing company and BIOMODEX partner focused on converting 2D medical imaging into 3D-printed anatomical models. Provides overlapping patient-specific anatomical model services to hospitals and competes for the same pre-operative planning use cases.

Others

• Stratasys: BIOMODEX's primary 3D printing hardware partner supplying the J750 Digital Anatomy printers. A strategic enabling partner rather than direct competitor, but Stratasys's broader medical 3D printing roadmap and direct hospital relationships could create future competitive overlap.

Emerging players

• Anatomage: Provider of virtual dissection tables and 3D anatomy visualization products used in medical education and patient consultation. Competes in the broader anatomy visualization and medical training category with software-based alternatives to BIOMODEX's physical anatomical models.
• Osso VR: VR-based surgical training platform used by surgeons, medical device companies, and hospitals for procedure rehearsal and device training. Adjacent competitor targeting the same medical device manufacturer training budgets that BIOMODEX addresses with its EVIAS Plus and LAACS solutions.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/biomodex
• Xx.com/biomodex
• Facebookfacebook.com/biomodex

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds3 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIOMODEX